Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats

Hypertension

Volumn 52, Issue 2, 2008, Pages 342-350

  Wei, Shun Guang ^a   Yu, Yang ^a   Zhang, Zhi Hua ^a   Weiss, Robert M ^a,b   Felder, Robert B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Heart failure; MAPK; Paraventricular nucleus of hypothalamus; PI3K; Renal sympathetic nerve activity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; UO 126; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART RATE; HEMODYNAMICS; HYPOTHALAMUS; IMMUNOFLUORESCENCE TEST; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; THALAMUS MIDLINE NUCLEUS; UPREGULATION; ACUTE DISEASE; ADRENERGIC SYSTEM; ANALYSIS OF VARIANCE; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; HEART FAILURE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 49849104800     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.110445     Document Type: Article

References (36)

1. Cohn JN. Abnormalities of peripheral sympathetic nervous system control in congestive heart failure. Circulation. 1990;82:I59-67.
2. Francis J, Weiss RM, Wei SG, Johnson AK, Felder RB. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1734-R1745.
3. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
4. Pinto YM, Buikema H, van Gilst WH, Lie KI. Activated tissue renin-angiotensin systems add to the progression of heart failure. Basic Res Cardiol. 1996;91(suppl 2):85-90.
5. Francis J, Wei SG, Weiss RM, Felder RB. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Endocrinol Metab. 2004;287:H2138-H2146.
6. Francis GS. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J. 1989; 118:642-648.
7. Zucker IH, Schultz HD, Li YF, Wang Y, Wang W, Patel KP. The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol. 2004;84:217-232.
8. Wei SG, Yu Y, Zhang ZH, Felder RB. Activated mitogen-activated protein kinase contributes to the up-regulation of angiotensin type 1 receptors in the brain of heart failure rats [abstract]. Circulation. 2006; 114:310.
9. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153-183.
10. Pellieux C, Sauthier T, Aubert JF, Brunner HR, Pedrazzini T. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice. J Hypertens. 2000;18:1307-1317.
11. Vaziri ND, Xu ZG, Shahkarami A, Huang KT, Rodriguez-Iturbe B, Natarajan R. Role of AT-I receptor in regulation of vascular MCP-I, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney Int. 2005;68:2787-2793.
12. Lu D, Yang H, Raizada MK. Angiotensin II regulation of neuromodulation: downstream signaling mechanism from activation of mitogen-activated protein kinase. J Cell Biol. 1996;135:1609-1617.
13. Dugourd C, Gervais M, Corvol P, Monnot C. Akt is a major downstream target of PI3-kinase involved in angiotensin H-induced proliferation. Hypertension. 2003;41:882-890.
14. Yang H, Raizada MK. Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci. 1999;19:2413-2423.
15. Boone E, Vandevoorde V, De Wilde G, Haegeman G. Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor. FEBS Lett. 1998;441:275-280.
16. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Rising C, Kubler W, Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol. 2000;20:940-948.
17. Hoffman GE, Smith MS, Verbalis JG. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol. 1993;14:173-213.
18. Vahid-Ansari F, Leenen FH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol. 1998;275:H2140-H2146.
19. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol. 1980; 194:555-570.
20. Loewy AD. Descending pathways to the sympathetic preganglionic neurons. Prog Brain Res. 1982;57:267-277.
21. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:R281-R283.
22. Wei SG, Felder RB. Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol. 2002;282:H890-H895.
23. Stocker SD, Cunningham JT, Toney GM. Water deprivation increases Fos immunoreactivity in PVN autonomic neurons with projections to the spinal cord and rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1172-R1183.
24. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience. 2000;100:549-556.
25. Shafton AD, Ryan A, Badoer E. Neurons in the hypothalamic paraventricular nucleus send collaterals to the spinal cord and to the rostral ventrolateral medulla in the rat. Dev Brain Res. 1998;801:239-243.
26. Osbom JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep. 2007;9:228-235.
27. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Beater IF, Saeed AE, Parmentier JH, Estes A, Malik KU. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension. 2000;36:604-609.
28. Seyedabadi M, Goodchild AK, Pilowsky PM. Differential role of kinases in brain stem of hypertensive and normotensive rats. Hypertension. 2001; 38:1087-1092.
29. Sheriff MJ, Fontes MA, Killinger S, Horiuchi J, Dampney RA. Blockade of ATI receptors in the rostral ventrolateral medulla increases sympathetic activity under hypoxic conditions. Am J Physiol Kegul Integr Comp Physiol. 2006;290:R733-R740.
30. Chan SH, Hsu KS, Huang CC, Wang LL, Ou CC, Chan JY. NADPH oxidase-derived Superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res. 2005;97:772-780.
31. Schrader LA, Birnbaum SG, Nadin BM, Ren Y, Bui D, Anderson AE, Sweatt JD. ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am J Physiol Cell Physiol. 2006;290:C852-C861.
32. Miura S, Zhang J, Matsuo Y, Saku K, Karaik SS. Activation of extra-cellular signal-activated kinase by angiotensin II-induced Gq-independent epidermal growth factor receptor transactivation. Hypertens Res. 2004; 27:765-770.
33. Zucker IH, Gao L. The regulation of sympathetic nerve activity by angiotensin II involves reactive oxygen species and MAPK. Circ Res. 2005;97:737-739.
34. Dziennis S, Habecker BA. Cytokine suppression of dopamine-beta- hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways. J Biol Chem. 2003;278:15897-15904.
35. Ye S, Zhong H, Duong VN, Campese VM. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension. 2002;39:1101-1106.
36. Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest. 2004;114: 652-658.